Latest News & Updates
Breaking News
7 hours ago
Simantini Singh Deo
Other trending news you may like to read
European Commission Approves Roche’s Lunsumio Subcutaneous For Adults With Relapsed Or Refractory Follicular Lymphoma After Two Or More Prior Therapies
EU grants conditional approval for Roche’s subcutaneous Lunsumio, offering faster, convenient treatment for relapsed or refractory follicular lymphoma.
Simantini Singh Deo
Elicio Therapeutics Appoints Marc J. Wolfgang As Chief Technology Officer, Bringing 30+ Years Of Biopharma Leadership In Cell Therapy, RNA Medicines, And Biologics
Elicio appoints Marc J. Wolfgang as CTO to strengthen manufacturing and CMC strategy ahead of key ELI-002 7P milestones.
Simantini Singh Deo
Libtayo® Gains EU Approval For Adjuvant Use In CSCC Patients At High Risk Of Recurrence, Offering First Immunotherapy Option Post-Surgery And Radiation
EU approves Libtayo as adjuvant therapy for high-risk CSCC, reducing recurrence risk and expanding its immunotherapy reach.
Simantini Singh Deo
Regeneron Secures FDA Approval For EYLEA HD In RVO With Extended Dosing Backed By QUASAR Trial Data
FDA approves EYLEA HD for RVO, offering extended dosing flexibility and reduced injection burden for retinal disease patients.
Vaibhavi M.
